查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1756477

人工智慧诊断市场（按组件、按诊断、按国家和地区）—2024 年至 2032 年的行业分析、市场规模、市场份额和预测

Artificial Intelligence in Diagnostics Market, By Component, By Diagnosis, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年诊断人工智慧市场规模价值 15.6712 亿美元，2024 年至 2032 年的复合年增长率为 22.5%。

诊断市场中的人工智慧-市场动态

对早期和准确疾病检测的需求不断增长

对早期精准诊断的日益重视是人工智慧诊断市场发展的主要驱动力。全球医疗保健系统都高度重视及时发现疾病，以改善患者预后并降低治疗成本。人工智慧透过快速分析医学影像、基因图谱和电子健康记录等复杂资料集，提升诊断准确性。这种能力有助于早期发现癌症、心血管疾病和神经系统疾病等疾病。因此，医院、诊所和诊断实验室越来越多地采用人工智慧工具，以最大限度地减少错误，加快诊断速度，并支持个人化治疗决策。

诊断市场中的人工智慧—关键见解

根据我们的研究分析师，全球诊断人工智慧市场预计在 2024 年至 2032 年期间的复合年增长率约为 22.5%。

2024 年按组件细分，软体类别占据了市场主导地位。

根据诊断，放射科部门在 2024 年创造了最多的收入。

按地区划分，2024年北美是收入最高的地区。

诊断市场中的人工智慧-細項分析：

全球诊断人工智慧市场分为三类：组件、诊断和区域。

诊断人工智慧市场按组件细分为软体、硬体和服务。其中，软体因其在处理资料、执行演算法和产生诊断输出方面的核心作用而成为主导部分。人工智慧软体解决方案对于解读医学影像、分析实验室结果和支援临床决策至关重要。这些平台透过机器学习不断发展，随着时间的推移提高准确性并适应复杂的诊断挑战。人工智慧软体与医院系统、电子健康记录 (EHR) 和影像设备的日益整合进一步巩固了其市场领导地位。此外，软体解决方案提供可扩展性、远端存取和成本效益，与通常需要更高前期投资和基础设施支援的硬体和服务组件相比，它们对医疗保健提供者更具吸引力。

人工智慧诊断市场按诊断细分为心臟病学、肿瘤学、病理学、放射学、胸肺、神经病学等。其中，放射学占据主导地位，因为它会产生大量影像资料，并且迫切需要准确的解释。人工智慧正在透过增强对X光、核磁共振成像、CT扫描和超音波的分析来彻底改变放射学，使其能够更快、更准确地检测肿瘤、骨折和内出血等异常情况。人工智慧演算法能够检测细微模式并减少诊断错误，使其成为放射科医生的宝贵工具。此外，对影像诊断的需求不断增长，尤其是在慢性病管理和急救护理方面，这继续推动人工智慧在放射学中的应用，巩固其市场领导地位。

诊断市场中的人工智慧—地理洞察

从地理分布来看，诊断人工智慧市场分布于北美、亚太、拉丁美洲、欧洲、中东和非洲。这些地区根据业务来源国进一步划分。

北美在诊断人工智慧市场占据主导地位，主要由美国推动。该地区受益于完善的医疗基础设施、对人工智慧技术的大量投资以及政府的支持性倡议。领先的科技公司和新创公司与医院合作开发先进的诊断工具，尤其是在放射科和肿瘤科领域。电子健康记录 (EHR) 的高采用率、慢性病盛行率的上升以及对精准医疗日益增长的需求进一步推动了市场成长。 FDA 等监管机构积极批准基于人工智慧的诊断工具，增强了人们对临床应用的信心。这些因素使北美成为人工智慧驱动诊断创新的全球领导者。

亚太地区正成为人工智慧诊断市场的关键成长区域，其中以中国、日本和印度等国家为主导。医疗保健领域的快速数位转型、人工智慧新创公司投资的不断增长以及政府对医疗科技创新的日益重视，正在推动市场扩张。该地区面临着患者数量庞大、慢性病发病率不断上升的局面，对可扩展、高效的诊断解决方案的需求强劲。此外，中国的人工智慧发展计画和印度推动数位化医疗等措施也强化了该地区的生态系统。当地医院与全球科技公司之间的合作正在加速人工智慧的普及，使亚太地区成为一个充满活力且快速扩张的市场。

诊断市场中的人工智慧-竞争格局：

人工智慧诊断市场的竞争态势由成熟的医疗和医疗科技巨头以及敏捷的新创公司共同塑造，这些公司推动创新。西门子医疗、通用电气医疗、Aidoc 和 Digital Diagnostics, Inc. 等公司凭藉专注于医学影像、心臟病学和病理学的强大人工智慧平台占据主导地位。这些领导者优先考虑研发投入、法规合规性和策略合作伙伴关係，以扩展其人工智慧产品组合。同时，Vuno, Inc. 和 NovaSignal Corporation 等新兴企业带来了颠覆性的解决方案，尤其是在神经病学和即时资料分析领域。这种良性竞争格局促进了产品的持续改进、人工智慧在诊断领域的更广泛应用，并增强了对医疗专业人员的临床决策支援。

最新动态：

2024 年 3 月，Aidoc 与美国放射学会合作，启动了一项全国性的临床 AI 部署计划，以增强中风和肺栓塞的检测。

2025 年 1 月，Vuno, Inc. 的人工智慧驱动的 VUNO Med-Chest X-ray(TM) 解决方案获得了欧洲 CE 认证，加速了其在欧盟医疗保健系统的扩张。

目录

第一章：人工智慧诊断市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 诊断市场中的人工智慧（按组件）
    • 诊断市场中的人工智慧（按诊断）
    • 各国诊断市场人工智慧片段
    • 诊断市场人工智慧（按地区）
  • 竞争洞察

第三章：诊断中的人工智慧关键市场趋势

  • 人工智慧诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 人工智慧诊断市场的限制
    • 市场限制的影响分析
  • 人工智慧在诊断市场的机会
  • 诊断市场人工智慧的未来趋势

第四章：诊断产业人工智慧研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：诊断市场中的人工智慧：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：人工智慧诊断市场格局

  • 2023年人工智慧诊断市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：诊断市场中的人工智慧 - 按组件

  • 概述
    • 按组件分類的细分市场占有率分析
    • 软体
    • 硬体
    • 服务

第 8 章：诊断市场中的人工智慧 - 按诊断

  • 概述
    • 按诊断进行细分份额分析
    • 心臟病学
    • 肿瘤学
    • 病理
    • 放射学
    • 胸部和肺部
    • 神经病学
    • 其他的

第九章：诊断市场中的人工智慧-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美诊断领域人工智慧主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按组件）
    • 北美市场规模及预测（按诊断）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲诊断领域人工智慧主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按组成部分）
    • 欧洲市场规模及预测（依诊断）
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区诊断领域人工智慧主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（按组成部分）
    • 亚太市场规模及预测（依诊断）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲诊断领域人工智慧主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按组成部分）
    • 拉丁美洲市场规模及预测（按诊断）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲诊断领域人工智慧主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按组成部分）
    • 中东和非洲市场规模及预测（按诊断）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第十章：关键供应商分析-诊断产业人工智慧

  • 竞争仪錶板
  • 公司简介
    • Siemens Healthineers
    • Zebra Technologies Corp.
    • Riverain Technologies
    • Vuno, Inc.
    • Aidoc
    • NovaSignal Corporation
    • Imagen
    • Digital Diagnostics, Inc.
    • GE Healthcare
    • AliveCor Inc.
    • F. Hoffmann-La Roche Ltd
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5269

REPORT HIGHLIGHT

Artificial Intelligence in Diagnostics Market size was valued at USD 1,567.12 Million in 2024, expanding at a CAGR of 22.5% from 2024 to 2032.

Artificial Intelligence in Diagnostics refers to the use of advanced algorithms and machine learning techniques to analyze medical data and assist in identifying diseases or conditions. By processing vast amounts of clinical information, imaging, and patient history, AI systems can detect patterns and anomalies often invisible to the human eye. This technology enhances accuracy, speeds up diagnosis, and supports healthcare professionals in making informed decisions. AI-driven diagnostics improve early disease detection, personalize treatment plans, and optimize healthcare outcomes while reducing errors and costs. It represents a transformative tool in modern medicine, integrating data science with clinical expertise.

Artificial Intelligence in Diagnostics Market- Market Dynamics

Rising Demand for Early and Accurate Disease Detection

The growing emphasis on early and precise diagnosis is a major driver for the AI in diagnostics market. Healthcare systems worldwide are prioritizing timely identification of diseases to improve patient outcomes and reduce treatment costs. Artificial Intelligence enhances diagnostic accuracy by swiftly analyzing complex datasets such as medical images, genetic profiles, and electronic health records. This capability supports early detection of conditions like cancer, cardiovascular diseases, and neurological disorders. As a result, hospitals, clinics, and diagnostic labs are increasingly adopting AI tools to minimize errors, accelerate diagnosis, and support personalized treatment decisions.

Artificial Intelligence in Diagnostics Market- Key Insights

According to our research analyst, the global Artificial Intelligence in Diagnostics Market is expected to develop at a CAGR of approximately 22.5% between 2024-2032.

Segmented by Component in 2024, the Software category dominated the market.

Based on Diagnosis, the Radiology segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Artificial Intelligence in Diagnostics Market- Segmentation Analysis:

The global Artificial Intelligence in Diagnostics Market is divided into Three categories: Component, Diagnosis, and Region.

The Artificial Intelligence in Diagnostics market is segmented by component into software, hardware, and services. Among these, software emerges as the dominant segment due to its central role in processing data, executing algorithms, and generating diagnostic outputs. AI-powered software solutions are integral for interpreting medical images, analyzing lab results, and supporting clinical decision-making. These platforms continuously evolve through machine learning, improving accuracy over time and adapting to complex diagnostic challenges. The growing integration of AI software with hospital systems, electronic health records (EHRs), and imaging equipment further strengthens its market leadership. Additionally, software solutions offer scalability, remote access, and cost-efficiency, making them more attractive to healthcare providers compared to hardware and service components, which often require higher upfront investments and infrastructure support.

The Artificial Intelligence in Diagnostics market, by diagnosis, is segmented into cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. Among these, radiology holds the dominant share due to the vast volume of imaging data it generates and the critical need for accurate interpretation. AI is revolutionizing radiology by enhancing the analysis of X-rays, MRIs, CT scans, and ultrasounds, enabling faster and more accurate detection of abnormalities such as tumors, fractures, and internal bleeding. The ability of AI algorithms to detect subtle patterns and reduce diagnostic errors makes them invaluable tools for radiologists. Furthermore, rising demand for imaging diagnostics, especially in chronic disease management and emergency care, continues to drive AI adoption in radiology, reinforcing its market leadership.

Artificial Intelligence in Diagnostics Market- Geographical Insights

Geographically, the Artificial Intelligence in Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Artificial Intelligence in Diagnostics market, primarily driven by the United States. The region benefits from a well-established healthcare infrastructure, significant investments in AI technologies, and supportive government initiatives. Leading tech firms and startups collaborate with hospitals to develop advanced diagnostic tools, especially in radiology and oncology. High adoption rates of electronic health records (EHRs), rising chronic disease prevalence, and increasing demand for precision medicine further fuel market growth. Regulatory bodies like the FDA actively approve AI-based diagnostic tools, boosting confidence in clinical applications. These factors position North America as a global leader in AI-driven diagnostic innovations.

Asia Pacific is emerging as a key growth region in the AI in Diagnostics market, led by countries such as China, Japan, and India. Rapid digital transformation in healthcare, growing investments in AI startups, and increasing government focus on health tech innovation are propelling market expansion. The region faces high patient volumes and rising incidences of chronic diseases, creating a strong demand for scalable, efficient diagnostic solutions. Additionally, initiatives like China's AI development plans and India's push for digital healthcare strengthen the ecosystem. Collaborations between local hospitals and global tech companies are accelerating AI adoption, making Asia Pacific a dynamic and rapidly expanding market.

Artificial Intelligence in Diagnostics Market- Competitive Landscape:

The competitive dynamics of the Artificial Intelligence in Diagnostics market are shaped by established healthcare and med-tech giants alongside agile startups driving innovation. Companies such as Siemens Healthineers, GE Healthcare, Aidoc, and Digital Diagnostics, Inc. dominate through robust AI platforms focused on medical imaging, cardiology, and pathology. These leaders prioritize R&D investments, regulatory compliance, and strategic partnerships to expand their AI portfolios. Meanwhile, emerging players like Vuno, Inc. and NovaSignal Corporation bring disruptive solutions, particularly in neurology and real-time data analysis. This healthy competitive mix promotes continuous product advancement, broader AI integration in diagnostics, and enhanced clinical decision support for healthcare professionals.

Recent Developments:

In March 2024, Aidoc partnered with the American College of Radiology to launch a nationwide clinical AI deployment initiative, enhancing stroke and pulmonary embolism detection.

In January 2025, Vuno, Inc. received European CE certification for its AI-powered VUNO Med-Chest X-ray(TM) solution, accelerating its expansion across EU healthcare systems.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Siemens Healthineers
  • Zebra Technologies Corp.
  • Riverain Technologies
  • Vuno, Inc.
  • Aidoc
  • NovaSignal Corporation
  • Imagen
  • Digital Diagnostics, Inc.
  • GE Healthcare
  • AliveCor Inc.
  • F. Hoffmann-La Roche Ltd
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY COMPONENT - MARKET ANALYSIS, 2019 - 2032

  • Software
  • Hardware
  • Services

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY DIAGNOSIS - MARKET ANALYSIS, 2019 - 2032

  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest and Lung
  • Neurology
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in Diagnostics Market Snippet by Component
    • 2.1.2. Artificial Intelligence in Diagnostics Market Snippet by Diagnosis
    • 2.1.3. Artificial Intelligence in Diagnostics Market Snippet by Country
    • 2.1.4. Artificial Intelligence in Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in Diagnostics Key Market Trends

  • 3.1. Artificial Intelligence in Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Diagnostics Market Opportunities
  • 3.4. Artificial Intelligence in Diagnostics Market Future Trends

4. Artificial Intelligence in Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Diagnostics Market Landscape

  • 6.1. Artificial Intelligence in Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Diagnostics Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Hardware
    • 7.1.4. Services

8. Artificial Intelligence in Diagnostics Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 8.1.2. Cardiology
    • 8.1.3. Oncology
    • 8.1.4. Pathology
    • 8.1.5. Radiology
    • 8.1.6. Chest and Lung
    • 8.1.7. Neurology
    • 8.1.8. Others

9. Artificial Intelligence in Diagnostics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Artificial Intelligence in Diagnostics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Artificial Intelligence in Diagnostics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Artificial Intelligence in Diagnostics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Artificial Intelligence in Diagnostics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Artificial Intelligence in Diagnostics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Artificial Intelligence in Diagnostics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Siemens Healthineers
    • 10.2.2. Zebra Technologies Corp.
    • 10.2.3. Riverain Technologies
    • 10.2.4. Vuno, Inc.
    • 10.2.5. Aidoc
    • 10.2.6. NovaSignal Corporation
    • 10.2.7. Imagen
    • 10.2.8. Digital Diagnostics, Inc.
    • 10.2.9. GE Healthcare
    • 10.2.10. AliveCor Inc.
    • 10.2.11. F. Hoffmann-La Roche Ltd
    • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us